2nd AnnualInvitation Only
Lung Cancer
USFocus Meeting 2027
Two days, 48 people, one room.
April 30 to May 1, 2027
NOPSI Hotel, New Orleans, LA
Dates
April 30-May 1, 2027
Two-day program
Venue
NOPSI Hotel
New Orleans, LA
Audience
48 by invitation
24 KOLs & 24 fellows
Format
8 sessions · 24 talks
Expert talks + moderated panels
A Curated Room: The People Shaping Practice
Now in its second year, this invitation-only meeting convenes a deliberately small faculty: 24 leading thoracic oncology KOLs alongside 24 hand-selected fellows and junior faculty, the clinicians defining today’s standards and the ones who will define the next decade’s, in one room for two days.
The science tracks where treatment is moving: immunotherapy in advanced and early-stage disease, oncogene-driven NSCLC from EGFR to fusions and rare mutations, small cell, and rare thoracic tumors. Every session pairs three expert talks with a moderated panel, sustained, close-quarters engagement rather than a lecture hall.
Advanced NSCLC ImmunotherapyEGFR, Fusions & Rare MutationsSmall Cell Lung CancerPerioperative & ConsolidationMRD & Liquid BiopsyMesothelioma · Thymic · MTAP
Meeting Co-Chairs
Charu Aggarwal
University of Pennsylvania, Philadelphia, PA
Stephen Liu
Georgetown Lombardi Comprehensive Cancer Center, Washington, DC
Faculty Drawn From
MD Anderson · Memorial Sloan Kettering · Dana-Farber · Johns Hopkins · Massachusetts General and other leading US cancer centers
48
Invited attendees only, sustained access, not a crowd
1:1
KOLs to rising faculty, a hand-picked balance in every session
14
Established US Focus Meetings behind it, a proven platform, not a one-off
Lung Cancer US Focus Meeting 2027
Faculty
Listed alphabetically by surname
Mariam Alexander
Medical University of South Carolina, Charleston, SC
Lyudmila Bazhenova
UC San Diego Health, La Jolla, CA
Christine Bestvina
The University of Chicago Medicine, IL
Hossein Borghaei
Fox Chase Cancer Center, Philadelphia, PA
Tina Cascone
MD Anderson Cancer Center, Houston, TX
Jamie Chaft
Memorial Sloan Kettering Cancer Center, New York, NY
Alexander Drilon
Memorial Sloan Kettering Cancer Center, New York, NY
Narjust Florez
Dana-Farber Cancer Institute, Boston, MA
Justin Gainor
Massachusetts General Hospital, Boston, MA
Ryan Gentzler
University of Virginia School of Medicine, Charlottesville, VA
Balazs Halmos
Albert Einstein College of Medicine, Bronx, NY
Brian Henick
Columbia University Irving Medical Center, New York, NY
Chul Kim
Georgetown University, Washington, DC
Ticiana Leal
Emory Winship Cancer Institute, Atlanta, GA
Jessica Lin
Massachusetts General Hospital, Boston, MA
Christine Lovly
City of Hope, Duarte, CA
Melina Marmarelis
University of Pennsylvania, Philadelphia, PA
Sandip Patel
UC San Diego Health, La Jolla, CA
Zofia Piotrowska
Massachusetts General Hospital, Boston, MA
Jonathan Riess
UC Davis Health, Sacramento, CA
Christian Rolfo
The Ohio State University Comprehensive Cancer Center, Columbus, OH
Ferdinandos Skoulidis
MD Anderson Cancer Center, Houston, TX
Liza Villaruz
UPMC Hillman Cancer Center, Pittsburgh, PA
Helena Yu
Memorial Sloan Kettering Cancer Center, New York, NY
Two Days, Eight Sessions
Agenda
Presentations15 min
Panel Discussions30 min
Coffee Breaks20 min
Lunch Breaks65 min
Day One · Friday, April 30, 2027
Session IImmunotherapy for Advanced NSCLC
ModeratorTBD
PD(L)1 Based Standards
Liza VillaruzUPMC Hillman Cancer Center, Pittsburgh, PA
ADC + IO and other Combinations
Jonathan RiessUC Davis Health, Sacramento, CA
Bispecific Antibodies
Hossein BorghaeiFox Chase Cancer Center, Philadelphia, PA
Panel Discussion
Coffee Break
Session IIAdvanced EGFR+
ModeratorTBD
First Line
Zofia PiotrowskaMassachusetts General Hospital, Boston, MA
Second Line +
Christine LovlyCity of Hope, Duarte, CA
Transformed EGFR
Helena YuMemorial Sloan Kettering Cancer Center, New York, NY
Panel Discussion
Lunch Break + Faculty and Fellow Photo
Session IIIAdvanced Fusion+
ModeratorTBD
ALK
Jessica LinMassachusetts General Hospital, Boston, MA
ROS1 and NTRK
Alexander DrilonMemorial Sloan Kettering Cancer Center, New York, NY
RET, NTRK, NRG1
Lyudmila BazhenovaUC San Diego Health, La Jolla, CA
Panel Discussion
Coffee Break
Session IVAdvanced Mutation+
ModeratorTBD
HER2
Christine BestvinaThe University of Chicago Medicine, IL
BRAF and MET
Ryan GentzlerUniversity of Virginia School of Medicine, Charlottesville, VA
KRAS
Ferdinandos SkoulidisMD Anderson Cancer Center, Houston, TX
Panel Discussion
Day Two · Saturday, May 1, 2027
Session VSmall Cell Lung Cancer
ModeratorTBD
Chemotherapy and Immunotherapy
Ticiana LealEmory Winship Cancer Institute, Atlanta, GA
T-Cell Engagers
Sandip PatelUC San Diego Health, La Jolla, CA
ADCs and Other Strategies
Brian HenickColumbia University Irving Medical Center, New York, NY
Panel Discussion
Coffee Break
Session VIRare Thoracic Tumors / Events
ModeratorTBD
Mesothelioma
Melina MarmarelisUniversity of Pennsylvania, Philadelphia, PA
Thymic Epithelial Tumors
Chul KimGeorgetown University, Washington, DC
MTAP Deleted Cancers
Mariam AlexanderMedical University of South Carolina, Charleston, SC
Panel Discussion
Lunch Break + Faculty and Fellow Photo
Session VIIImmunotherapy in Early Stage
ModeratorTBD
Neoadjuvant and Perioperative Standards
Tina CasconeMD Anderson Cancer Center, Houston, TX
Future Directions for Neoadjuvant and Perioperative
Balazs HalmosAlbert Einstein College of Medicine, Bronx, NY
Consolidation after Chemoradiation
Justin GainorMassachusetts General Hospital, Boston, MA
Panel Discussion
Coffee Break
Session VIIITargeted Therapy in Early Stage
ModeratorTBD
Neoadjuvant + Adjuvant TKIs
Jamie ChaftMemorial Sloan Kettering Cancer Center, New York, NY
Consolidation TKIs post CRT
Narjust FlorezDana-Farber Cancer Institute, Boston, MA
MRD / Liquid Biopsy
Christian RolfoThe Ohio State University Comprehensive Cancer Center, Columbus, OH
Panel Discussion
Partnership Opportunities Now Open
Bespoke engagement packages for a closed, invitation-only audience
Request the Prospectus →